Published in Br J Anaesth on March 01, 2014
Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth (2014) 0.86
Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency. J Pharm Policy Pract (2017) 0.75
Intraoperative hydroxyethyl starch 70/0.5 administration may increase postoperative bleeding: a retrospective cohort study. J Anesth (2017) 0.75
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet (2000) 8.08
A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med (2015) 4.95
Rationing intensive care. BMJ (1995) 3.90
Weaning from mechanical ventilation. Eur Respir J (2007) 3.59
Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med (1997) 3.31
Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution. Intensive Care Med (2000) 2.97
Mechanism of grass-pollen-induced asthma. Lancet (1992) 2.92
Quantitative physical chemistry analysis of acid-base disorders in critically ill patients. Anaesthesia (2001) 2.70
Acute renal failure: time for consensus. Intensive Care Med (2001) 2.53
Use of consensus development to establish national research priorities in critical care. BMJ (2000) 2.52
Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth (2007) 2.41
Intra-atrial ECG is not a reliable method for positioning left internal jugular vein catheters. Br J Anaesth (2003) 2.21
Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med (2001) 2.17
Transanal haemorrhoidal artery echodoppler ligation and anopexy (THD) is effective for II and III degree haemorrhoids: a prospective multicentric study. Colorectal Dis (2010) 2.11
[Effectiveness of pulmonary artery catheterization in the critically ill patient--attempt at evaluating current status]. Anasthesiol Intensivmed Notfallmed Schmerzther (1997) 2.02
Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology (2000) 2.02
The effects of plasmalyte-148 vs. Hartmann's solution during major liver resection: a multicentre, double-blind, randomized controlled trial. Minerva Anestesiol (2014) 2.01
[Anti-inflammatory treatment in sepsis]. Chirurg (2002) 2.00
Predicting fluid responsiveness with transthoracic echocardiography is not yet evidence based. Acta Anaesthesiol Scand (2012) 1.99
Comparison of pulmonary artery and arterial thermodilution cardiac output in critically ill patients. Intensive Care Med (1999) 1.85
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Renal blood flow in experimental septic acute renal failure. Kidney Int (2006) 1.83
Myocardial cell injury in septic shock. Crit Care Med (1999) 1.82
Multiple organ failure: from basic science to prevention. Br J Anaesth (1996) 1.75
Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs (2007) 1.73
Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice. Minerva Anestesiol (2010) 1.73
Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med (2010) 1.68
Release of lactate by the lung in acute lung injury. Chest (1997) 1.66
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection (2009) 1.64
Effects of staff training on the care of mechanically ventilated patients: a prospective cohort study. Br J Anaesth (2009) 1.63
Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med (1999) 1.62
Optimized method for correct left-sided central venous catheter placement under electrocardiographic guidance. Br J Anaesth (2011) 1.55
Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine. Crit Care Med (1999) 1.54
Patients with faecal peritonitis admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Intensive Care Med (2013) 1.52
High-volume haemofiltration in human septic shock. Intensive Care Med (2001) 1.52
Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. Epilepsia (1999) 1.50
Current oxygenation practice in ventilated patients-an observational cohort study. Anaesth Intensive Care (2013) 1.45
Variability of splanchnic blood flow in patients with sepsis. Intensive Care Med (2001) 1.44
A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group. Crit Care Med (1995) 1.44
The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Crit Care Resusc (2002) 1.43
Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut (2005) 1.43
Postoperative hypothermia and patient outcomes after elective cardiac surgery. Anaesthesia (2011) 1.43
Oxygen consumption and lactate release by the lung after cardiopulmonary bypass and during septic shock. Crit Care Resusc (2000) 1.42
The European Union Directive on Clinical Research: present status of implementation in EU member states' legislations with regard to the incompetent patient. Intensive Care Med (2005) 1.42
Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration. Crit Care Med (1999) 1.42
Use of selective digestive tract decontamination in European intensive cares: the ifs and whys. Minerva Anestesiol (2014) 1.41
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med (2001) 1.41
Effect of mild hypothermia on cerebral oxygen uptake during gradual cerebral perfusion pressure decrease in piglets. Crit Care Med (2000) 1.40
Incidence and predictors of central venous catheter related infection in intensive care patients. Anaesth Intensive Care (1999) 1.40
Comparison of the performance of SAPS II, SAPS 3, APACHE II, and their customized prognostic models in a surgical intensive care unit. Br J Anaesth (2008) 1.40
Plasma acid-base changes in chronic renal failure: a Stewart analysis. Int J Artif Organs (2005) 1.39
[Supportive and adjunctive sepsis therapy]. Internist (Berl) (2009) 1.38
Comments on Efendijev et al.: temporal trends in cardiac arrest incidence and outcome in Finnish intensive care units from 2003 to 2013. Intensive Care Med (2015) 1.38
Effect of perfusion pressure on the splanchnic circulation after CPB: a pilot study. Minerva Anestesiol (2014) 1.37
Potential hazards in estimation of gastric intramucosal pH. Lancet (1992) 1.37
Procalcitonin--a new indicator of the systemic response to severe infections. Infection (1998) 1.36
Defining death in non-heart beating organ donors. J Med Ethics (2003) 1.32
Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect (2002) 1.31
Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med (1999) 1.27
Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock (1998) 1.25
Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care (2002) 1.23
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci U S A (1998) 1.22
Oral naloxone reverses opioid-associated constipation. Pain (2000) 1.20
Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med (1999) 1.19
The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection (2008) 1.18
A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med (2000) 1.18
The aetiology and pathogenesis of cardiopulmonary bypass-associated metabolic acidosis using polygeline pump prime. Intensive Care Med (1999) 1.17
Outcomes in intensive care. BMJ (1993) 1.17
Dysfunction of vasomotor reactivity in severe sepsis and septic shock. Intensive Care Med (2001) 1.16
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. J Exp Med (1991) 1.15
Estimating unmeasured anions in critically ill patients: anion-gap, base-deficit, and strong-ion-gap. Anaesthesia (2002) 1.14
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol (1997) 1.14
The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol (2001) 1.14
Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med (2000) 1.13
Questionnaire-based survey on structural quality of hospitals and nursing homes for the elderly, their staffing with infection control personal, and implementation of infection control measures in Germany. GMS Hyg Infect Control (2013) 1.13
Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron (1993) 1.12
The acid-base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration. Int J Artif Organs (2008) 1.11
Transoesophageal echocardiographic assessment of haemodynamic changes during laparoscopic herniorrhaphy in small children. Br J Anaesth (2000) 1.10
Comparison between intrathoracic blood volume and cardiac filling pressures in the early phase of hemodynamic instability of patients with sepsis or septic shock. J Crit Care (1999) 1.10
Out of hospital outcome and quality of life in survivors of combined acute multiple organ and renal failure treated with continuous venovenous hemofiltration/hemodiafiltration. Intensive Care Med (1997) 1.10
The 3rd International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Int J Artif Organs (2005) 1.09
Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med (1999) 1.08
Failure of continuous cardiac output measurement using the PiCCO Device during induced hypothermia: a case report. Crit Care Resusc (2004) 1.08
Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesth Intensive Care (2005) 1.08
Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs (2001) 1.07
Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol (1999) 1.07
Strong ions, weak acids and base excess: a simplified Fencl-Stewart approach to clinical acid-base disorders. Br J Anaesth (2004) 1.07
Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med (1994) 1.06
High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost (2012) 1.05
Hepatic anion flux during acute endotoxemia. J Appl Physiol (1985) (1995) 1.05
Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med (2000) 1.05
Acute Dialysis Quality Initiative (ADQI): methodology. Int J Artif Organs (2008) 1.04
Nurses' attitudes to a medical emergency team service in a teaching hospital. Qual Saf Health Care (2006) 1.04
Impact of continuous veno-venous hemofiltration on acid-base balance. Int J Artif Organs (2003) 1.03
The utility of open lung biopsy in patients requiring mechanical ventilation. Chest (1999) 1.01
Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock (2001) 1.01